NHS Greenlights Puberty Blocker Trial for Transgender Youth with New Age Limits Saturday, June 20, 2026 nhs transgender pubertyblockers mhra trial consent genderdysphoria healthcare ethics children The NHS has confirmed it will proceed with a contentious trial involving puberty-blocking drugs for transgender children, setting minimum age limits of 11 for girls and 12 for boys. This decision follows a compromise from the … Read More